Hints and tips:
Related Special Reports
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
US biotech has been struggling to overcome fall in demand for coronavirus jabs
...Future sales for Pfizer will depend on the wild card of new variants that evade previous protection....
...This was driven by a surge in prescriptions of Sandoz’s Hyrimoz, CVS’s preferred biosimilar, which was given to more than 10,000 patients in the week ending April 12, pushing biosimilars’ share of new Humira...
...How certain could he have been that Incyte would rise on the Medivation deal news? Companies warn their employees about trading in their employer’s shares....
...Additional reporting by Oliver Barnes in New York...
...The rise and fall of WeightWatchers Sistani describes the new WW as a judgment-free “weight health” company embracing “a full spectrum of solutions”....
...Some doctors believe there has been excessive caution over the new Alzheimer’s drugs....
...The company has been working with the pharmaceutical giant GSK, focusing on immuno-oncology drugs....
...J&J was valued at $367bn, as of market close in New York on Thursday....
...US-based hedge fund Shah Capital wrote to the Novavax board on Monday to push for the instalment of two new independent board directors....
...Born in 1947 in New Jersey like Auster himself, the story of Archibald Ferguson is determined and redetermined....
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
...Pharmaceuticals groups Pfizer and Moderna, which have both faced criticism from fringe groups over their Covid-19 vaccines, also spent heavily on security for their CEOs last year....
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
A weight loss titan fights to stay relevant in the age of GLP-1 drugs
...The sale of Catalent comes after the New Jersey-based company had faced calls from activist investor Elliott to shake up its board and improve the performance of its shares....
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
...New York-listed shares lost 8.2 per cent shortly after the open, after losing 49 per cent this year....
...The landmark lawsuit filed on Thursday in federal court in New Jersey by the US Department of Justice, along with a bipartisan group of 16 state and district attorneys, accuses the group of imposing contractual...
...The cases that settled were being fought in New Jersey and Delaware. AstraZeneca said the specific terms of the agreement remained confidential....
Millions of Paxlovid pills have gone unused as tight controls restrict access
...Shares in Pfizer fell 5 per cent in in New York on Friday after the group said more than half of the participants in its clinical trial for the new drug had dropped out because of side effects....
...The DoJ’s case, he said, “avoids some of the vulnerabilities” from Epic’s fight, and the case law governing the New Jersey federal court where the lawsuit was filed may be more favourable to the government...
...Spirit had also committed to let go of gates and other facilities in airports including Newark, New Jersey. The offers, however, did not sway Young: “Spirit is a small airline....
International Edition